SJ Medical
SJ Medical
The global medical landscape has seen a paradigm shift in vascular intervention. Historically, femoral access was the gold standard; however, the Transradial Access (TRA) approach has rapidly become the preferred method for diagnostic and interventional procedures worldwide. Consequently, the demand for high-quality Radial Artery Compression Devices has skyrocketed. These devices are critical in managing post-procedural hemostasis, ensuring that the radial artery is compressed sufficiently to prevent bleeding while maintaining distal patency.
In North America and Europe, clinical guidelines increasingly favor radial access due to significantly lower rates of major bleeding and vascular complications compared to femoral access. This transition has birthed a multi-billion dollar market for specialized hemostasis bands and compression systems.
Aging global populations and the rising prevalence of cardiovascular diseases (CVD) are driving the volume of PCI (Percutaneous Coronary Intervention). Market analysis suggests a CAGR of over 6% for radial hemostasis devices through 2030.
Global procurement teams from leading hospitals and medical distribution networks are no longer just looking for a "plastic band." They are seeking "Patent Hemostasis" solutions. This means the device must offer transparent visibility for site monitoring, ergonomic pressure adjustment (often via air-injected balloons), and biocompatible materials that reduce skin irritation during the 2–6 hour wear time.
When searching for a Radial Artery Compression Device supplier, China has emerged as the global manufacturing hub that balances innovation with cost-efficiency. As a leading manufacturer, Hangzhou SJ Medical Co., Ltd. exemplifies the best of Chinese medical engineering.
Our expertise is rooted in nearly a decade of dedicated research. SJ Medical doesn't just manufacture; we innovate. Our technical team, led by industry veterans with decades of experience, ensures that every device—from vascular sheaths to balloon catheters—meets the rigorous demands of modern cath labs. By integrating precision engineering with clinical feedback, we have developed products that compete with top-tier global brands while offering the manufacturing flexibility of a direct factory.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes. The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades.
The company is equipped with advanced production and inspection systems, including precision balloon forming equipment, laser welding, and comprehensive laboratory testing facilities.
SJ Medical strictly adheres to international quality standards. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval.
In the competitive world of medical supply chain management, procurement officers from India, Brazil, the Middle East, and Europe face the challenge of balancing quality and cost. As a premium Radial Artery Compression Device supplier, we address several critical procurement needs:
Whether it is a high-volume cardiac center in Italy or a specialized clinic in Indonesia, the application of our radial artery compression device remains consistent: providing patient comfort while ensuring clinical safety. The transparent design of our bands allows nurses to monitor the puncture site without removing the device, a feature highly praised by medical staff in France and the Netherlands.
The industry is moving toward "Smart Compression." Future iterations of Radial Artery Compression Devices may integrate pressure sensors that provide real-time feedback to monitoring systems. At SJ Medical, we are already investigating materials that improve moisture wicking and reduce the risk of Radial Artery Occlusion (RAO).
Our commitment to the global market is evidenced by our expansion into countries such as Finland, Spain, Turkey, and Egypt. We don't just sell products; we provide a complete service lifecycle—from pre-sales technical consultation to responsive after-sales support. This holistic approach ensures that SJ Medical remains a trusted name in vascular intervention.
